Building Clinical Expertise in ATTR-CM Management

Guest: Sumeet Mitter MD, MSc, FACC As advances in RNA silencers, gene-editing technologies, and immunotherapy reshape the ATTR-CM landscape, it's important to stay informed and build confidence navigating this increasingly complex field. Dr. Sumeet Mitter, Director of Inova Schar Heart and Vascular Research and the Infiltrative and Restrictive Cardiomyopathy Center at Inova Health in Virginia, shares practical advice about navigating the nuances of this rare disease.